Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1849-2026

Medline Industries, LP recalls Medline Kits: 1) BWNBORO CRANIOTOMY PACK-LF

Medline Industries, LPNorthfield, IL, United StatesReported Apr 29, 2026 · 2 months ago
Legal News Analyst ·

Reason for recall

The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Medline Kits: 1) BWNBORO CRANIOTOMY PACK-LF, Model Number: DYNJ32841F; 2) CRANIOTOMY PACK-LF, Model Number: DYNJ46069D 3) CAMPUS EXTREMITY PK, Model Number: DYNJ51935A 4) FOOT -XRAY BOWL MEDCUP SPECCUP, Model Number: DYNJ68902A 5) RADIOLOGY SPINE PACK, Model Number: DYNJ80679A 6) DR CHA CUSTOM PACK, Model Number: DYNJ82370A 7) SPINE PACK HC, Model Number: DYNJ84272

Lot / code information

UDI
10195327037796(each), 40195327037797(case)
Lot #
24CBF407; 2) DYNJ46069D
UDI
10193489493184(each), 40193489493185(case)
Lot #
24KBG704; 3) DYNJ51935A
UDI
10889942735549(each), 40889942735540(case)
Lot #
24BME364; 4) DYNJ68902A
UDI
10193489870411(each), 40193489870412(case)
Lot #
24BMC999; 5) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
22KBJ690; 6) DYNJ80679A
Show 40 more code fields
UDI
10195327273705(each), 40195327273706(case)
Lot #
23BBD696; 7) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23DBG588; 8) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23FBD221; 9) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23GBN050; 10) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23IBB710; 11) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23LBM277; 12) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
24CBN011; 13) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
24DBK248; 14) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
24GBC694; 15) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
24HBX136; 16) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
24IBR538; 17) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
25ABC728; 18) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
25CBE147; 19) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
25CBP816; 20) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
23JBS196; 21) DYNJ80679A
UDI
10195327273705(each), 40195327273706(case)
Lot #
25EBM284; 22) DYNJ82370A
UDI
10198459220227(each), 40198459220228(case)
Lot #
25BBT096; 23) DYNJ82370A
UDI
10198459220227(each), 40198459220228(case)
Lot #
25DBO043; 24) DYNJ84272
UDI
10195327349882(each), 40195327349883(case)
Lot #
24KBE401; 25) DYNJ84272
UDI
10195327349882(each), 40195327349883(case)
Lot #
25BBO542

What the firm is doing

An URGENT MEDICAL DEVICE RECALL dated 2/25/26 was sent to customers. REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and lot number(s) listed in the recall portal. Quarantine all affected product. 2. Complete your response form. List the quantity of affected product you have in inventory on the form. Even if you do not have any affected product, submit the form to Website link: https://recalls.medline.com Recall Reference #: R-26-020-FGX1 Recall Code: 3. When we receive your response form, we will send over-labels via FedEx overnight to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Include your customers quantities on your response form. When we receive your response form, we will send over-labels to provide to your customers. Any questions? Contact the Recall Department at 866-359-1704 or recalls@medline.com. *** An Urgent Medical Device Recall notification letter dated 3/2/26 was sent to customers. This is a follow-up to a Medline notification you may have received on February 25, 2026. New item numbers and lot numbers have been included with this communication. Recipients receiving this notification for the first time were not affected by the original notification. REQUIRED ACTIONS: same as for 2/25/26 letter

DistributionShow details

US Nationwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls